By Sarianne Gruber – In a recent conversation with WPC Healthcare’s Chief Data Scientist, Damian Mingle shares how he developed an algorithm for detecting West Nile disease, which will be presented in Sri Lanka at the Global Public Health Conference in December 2015.
Read More
By Sarianne Gruber – Part 2 of an interview with Elizabeth Stuart, PhD a professor of Mental Health, Biostatistics, and Health Policy and Management at Johns Hopkins Bloomberg School of Public Health.
By Sarianne Gruber – A statistician by training, Elizabeth Stuart, PhD is a professor of Mental Health, Biostatistics, and Health Policy and Management at Johns Hopkins Bloomberg School of Public Health, and in the age of Electronic Health Records (EHRs), her research on developing and applying methods to estimate causal effects is a hot button topic.
By Sarianne Gruber – How effective is diagnosis in healthcare? Constantine Gatsonis PhD, Professor and Chair of the Department of Biostatistics at Brown University, has been asking this question for over twenty years with diagnostic imaging studies.
By Sarianne Gruber – The aging population in the US brings with it special concerns that will inevitably change the focus of many healthcare providers and organizations. Press Ganey, a leader in patient experience measurement, released last month its newest research on Patient Experience in the Very Elderly: An Emerging Strategic Focus.
By Sarianne Gruber – Apervita has conceived a common way for sharing information, and coined it “a democratization of health knowledge”. They have unlocked analytics as a self-service and removed the need to hard code algorithms to a given data model.
By Sarianne Gruber – VP of IBM Watson Health, Dr. Kathleen McGroddy Goetz is focused on technology and commercialization where “the pace has been very busy”. Kathy has been instrumental in many of new acquisitions and partnerships for IBM Watson Health including Phytel, a population health software, and Softlayer for Cloud Computing.
By Sarianne Gruber – Dr. Kathleen McGroddy Goetz, though she prefers to be called Kathy, describes her career as a journey. A trained academic in healthcare and life sciences with a research perspective, her first aspiration was to do drug discovery.
By Sarianne Gruber – What does it take to scale innovation across a very large enterprise and maximize impact? You might want to ask Marti Nyman. He is the Vice President of Business Development and Commercialization for UnitedHealthcare (UHC). And if you ask Marti what it takes, his answer is the “human touch.”